JUNSJupiter Neurosciences, Inc.

JUNS Stock Price, Valuation & Chart | Jupiter Neurosciences, Inc.

Compare

$3.430+0.08 (+2.39%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology JUNS intrinsic value JUNS calculated fair value vs price

Overview Financials Dividends Ratios

JUNS Historical price chart

JUNS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.66M

PE Ratio-12.7

EPS-0.27

Trading Volume34.90K

Today's High/Low3.52/3.31

Dividend Yield0.00

52 Week High/Low138.0/2.88

Shares Outstanding484.67K

JUNS Financial Statement

JUNS Analyst ratings

JUNS Analysis & performance metrics

JUNS Company profile

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of…

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is…

JUNS Management team

Name

Position

Claes Wahlestedt M.D., Ph.D.

Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer

Shaun P. Brothers Ph.D.

Co-Founder Member of Scientific Advisory Board & Consulting Vice President of Science Research

Alison D. Silva MA, MSCTO

President, Chief Business Officer & Director

Marshall Hayward Ph.D.CTO

Co-Founder, Chief Scientific Officer & Director

Saleem Elmasri CPACFO

Chief Financial Officer & Secretary

Christer RosenCEO

Co-Founder, Chief Executive Officer & Chairman of the Board

Alexander Rosen

Co-Founder & Chief Administrative Officer

Name

Position

Claes Wahlestedt M.D., Ph.D.

Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer

Shaun P. Brothers Ph.D.

Co-Founder Member of Scientific Advisory Board & Consulting Vice President of Science Research

Alison D. Silva MA, MSCTO

President, Chief Business Officer & Director

Marshall Hayward Ph.D.CTO

Co-Founder, Chief Scientific Officer & Director

Saleem Elmasri CPACFO

Chief Financial Officer & Secretary

Christer RosenCEO

Co-Founder, Chief Executive Officer & Chairman of the Board

Alexander Rosen

Co-Founder & Chief Administrative Officer

Management Team

Claes Wahlestedt M.D., Ph.D.

Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer

Shaun P. Brothers Ph.D.

Co-Founder Member of Scientific Advisory Board & Consulting Vice President of Science Research

Alison D. Silva MA, MSCTO

President, Chief Business Officer & Director

Marshall Hayward Ph.D.CTO

Co-Founder, Chief Scientific Officer & Director

Saleem Elmasri CPACFO

Chief Financial Officer & Secretary

Christer RosenCEO

Co-Founder, Chief Executive Officer & Chairman of the Board

Alexander Rosen

Co-Founder & Chief Administrative Officer

Management

Claes Wahlestedt M.D., Ph.D.

Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer

Shaun P. Brothers Ph.D.

Co-Founder Member of Scientific Advisory Board & Consulting Vice President of Science Research

Alison D. Silva MA, MSCTO

President, Chief Business Officer & Director

Marshall Hayward Ph.D.CTO

Co-Founder, Chief Scientific Officer & Director

Saleem Elmasri CPACFO

Chief Financial Officer & Secretary

Christer RosenCEO

Co-Founder, Chief Executive Officer & Chairman of the Board

Alexander Rosen

Co-Founder & Chief Administrative Officer

Total 7 executives

JUNS Frequently asked questions

What is Jupiter Neurosciences, Inc. (JUNS) Stock Price?

Current stock price of Jupiter Neurosciences, Inc. (JUNS) stock is $3.430. The stock price is +2.39% higher in the session. The intraday range can be seen from this page. Volume of Jupiter Neurosciences, Inc. (JUNS) stock is 34.90K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Jupiter Neurosciences, Inc. (JUNS) stock price going up or down today?

The stock price of Jupiter Neurosciences, Inc. (JUNS) can change with earnings, company news, and overall market sentiment. Jupiter Neurosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Jupiter Neurosciences, Inc. stock expensive at its current price?

Whether Jupiter Neurosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for JUNS on this page is -12.70. EPS on this page is -0.27. Compare those figures with peers and growth expectations before deciding if the current Jupiter Neurosciences, Inc. price is justified.

How has the stock price of Jupiter Neurosciences, Inc. (JUNS) performed historically?

Historical performance for Jupiter Neurosciences, Inc. (JUNS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how JUNS reacted to past earnings and market events.

Should I buy Jupiter Neurosciences, Inc. (JUNS) stock, at this price?

Buying Jupiter Neurosciences, Inc. (JUNS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.